News
Business
Economy
Politics
Technology
Environment
Search
Monday, January 13, 2025
No menu items!
News
Business
Economy
Politics
Technology
Environment
Search
Home
Moderna signs $35 million deal with cancer drug developer CytomX
FILE PHOTO: A sign marks the headquarters of Moderna in
FILE PHOTO: A sign marks the headquarters of Moderna in
FILE PHOTO: A sign marks the headquarters of the coronavirus disease (COVID-19) vaccine maker Moderna in Cambridge, Massachusetts, U.S., April 28, 2022. REUTERS/Brian Snyder
- Advertisment -
Most Read
Apple’s new fees for app developers under fresh EU scrutiny, Bloomberg reports
January 13, 2025
Factbox-LA blaze damage likely to be largest wildfire insured loss in US history
January 13, 2025
Eli Lilly to buy Scorpion Therapeutics’ cancer therapy for up to $2.5 billion
January 13, 2025
Cleveland-Cliffs partners with Nucor to potentially bid for US Steel, CNBC reports
January 13, 2025
We use cookies to ensure that we give you the best experience on our website.
Ok